Randomized trial shows persistent HPV 12 months post-thermal ablation in Malawian women, suggesting enhanced follow-up is needed for cancer prevention.
Over one-third of women had persistent hrHPV 12 months after TA, with higher rates among WLWH, primarily for non-16/18/45 genotypes. Findings highlight the need for enhanced follow-up and adjunct therapies to improve post-treatment clearance and advance cervical cancer prevention in low-resource settings.
No takes yet. Share an insight, caveat, or question.
Gingles et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: